Custom Manufacturing, Project Outsourcing, your Trusted Partner from China
NINGBO INNO PHARMCHEM CO.,LTD. is at the forefront of supplying critical pharmaceutical intermediates, with 8-Bromo-3-methyl-xanthine (CAS 93703-24-3) being a cornerstone of our product line. This compound is indispensable in the pharmaceutical industry, primarily recognized for its role in the synthesis of Linagliptin, a leading medication for managing type 2 diabetes. Understanding the significance of this intermediate is key to appreciating advancements in diabetes care.
The synthesis of 8-Bromo-3-methyl-xanthine involves precise chemical processes, ensuring a high level of purity, typically above 99.0%. This purity is paramount for its application in drug manufacturing, where even minor impurities can affect the efficacy and safety of the final pharmaceutical product. As a dedicated 8-Bromo-3-methyl-xanthine supplier in China, NINGBO INNO PHARMCHEM CO.,LTD. adheres to rigorous quality control measures throughout its production cycle. Our commitment ensures that clients receive a product that meets the highest industry standards, facilitating the reliable production of life-changing medications.
The demand for high-quality pharmaceutical intermediates like 8-Bromo-3-methyl-xanthine is driven by the growing global prevalence of type 2 diabetes. Linagliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor, offers an effective treatment option by improving glycemic control. The efficient synthesis of Linagliptin directly relies on the availability of pure 8-Bromo-3-methyl-xanthine. This connection highlights the intricate supply chain and the importance of reliable manufacturers like NINGBO INNO PHARMCHEM CO.,LTD. in ensuring medication accessibility.
Beyond its primary role in diabetes treatment, 8-Bromo-3-methyl-xanthine is also investigated for its potential in synthesizing other bioactive purine drugs, including antiviral and anti-tumor agents. This versatility underscores its importance as a valuable building block in medicinal chemistry and drug discovery. Researchers are continuously exploring new applications, further cementing the compound's status as a key intermediate in pharmaceutical R&D. NINGBO INNO PHARMCHEM CO.,LTD. is proud to support these ongoing efforts by providing consistent and high-quality supply.
For pharmaceutical companies and research institutions seeking a dependable source for 8-Bromo-3-methyl-xanthine, NINGBO INNO PHARMCHEM CO.,LTD. offers competitive pricing and unwavering quality. Our expertise in fine chemical synthesis and our dedication to customer satisfaction make us a preferred partner for your pharmaceutical intermediate needs. Contact us today to learn more about our products and how we can support your drug development and manufacturing processes.
Manufacturing Facilities
Professional Export Experience
to Global Customers
1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;
2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;
3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).
A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.
A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.
A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.
